Inogen Profit Margin

Inogen (INGN) currently reports a profit margin of -7.08% as of March 2026. That compares with -8.08% in the prior-year period — up 12.4% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Inogen's profit margin history and peer comparisons.

Inogen's profit margin increased from -8.08% to -7.08% — a 12.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Inogen's profit margin of -7.08% is lower than the Healthcare sector average of 15.29%. That is roughly 146.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Inogen's current -7.08% should be judged against Healthcare norms (sector average: 15.29%) and against INGN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -7.08%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Inogen, and consider following INGN for alerts when major investors trade the stock.